Surgery Partners, Inc. (NASDAQ: SGRY) had its price target lowered by analysts at Macquarie from $35.00 to $34.00. They now have an "outperform" rating on the stock.
Surgery Partners Inc (SGRY) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and ... [Yahoo! Finance]
Surgery Partners, Inc. Announces Third Quarter 2024 Results
Earnings To Watch: Surgery Partners Inc (SGRY) Reports Q3 2024 Result [Yahoo! Finance]
Surgery Partners (SGRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release [Yahoo! Finance]